Amlodipine improves the anti-ischaemic effect of atenolol in postinfarction patients with effort-induced ischaemia. An echostress study

Clinical Drug Investigation

Volumn 13, Issue SUPPL. 1, 1997, Pages 22-28

  Silva, Pedro ^a,b   Temporelli, Pier Luigi ^a   Imparato, Alessandro ^a   Giannuzzi, Pantaleo ^a   Giordano, Amerigo ^a  

^a IRCCS   (Italy)

^b Centro Medico di Riabilitazione   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; ASTHENIA; BRADYCARDIA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; LIVER TOXICITY; MALE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; ST SEGMENT; TREADMILL EXERCISE;

EID: 0030739770     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199700131-00006     Document Type: Article

References (28)

1. Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomised trials. Prog Cardiovasc Dis 1985; 27: 335
2. Astrom H. Hemodynamic effects of β-adrenergic blockade. Br Heart J 1968; 30: 40-51
3. Rice KR, Gervino E, Walfram R, et al. Effects of nifedipine on myocardial perfusion during exercise in chronic stable angina pectoris. Am J Cardiol 1990; 65: 1097-1101
4. Kinnard DR, Harris M, Hossack KF. Endurance testing for evaluation of antianginal therapy with amlodipine, a calcium channel blocking agent. J Am Coll Cardiol 1988; 12: 791-6
5. Lam J, Chaitman BR, Crean P, et al. A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects. J Am Coll Cardiol 1985; 6: 447-52
6. HINT Research Group (Holland Interuniversity Nifedipine/Metoprolol Trial). Early treatment of unstable angina in the coronary care unit: a randomised double blind placebo controlled comparison of recurrent ischemia in patients treated with nifedipine or metoprolol or both. Br Heart J 1986; 56: 400-13
7. Specchia G, deServi S, Falcone C, et al. Effects of nifedipine on coronary hemodynamic findings during exercise in patients with stable exertional angina. Circulation 1983; 68: 1035-43
8. Tweddel AC, Johnson J, Pringle TH, et al. The systemic and coronary hemodynamic effects of felodipine in patients with coronary artery disease. Eur Heart J 1983; 4: 699-705
9. Kaplinsky E. Management of angina pectoris. Modern concepts. Drugs 1992; 43 Suppl. 1: 9-14
10. Lai C, Onnis E, Orani E. Felodipine improves the anti-ischaemic effect of metoprolol in stable effort-induced angina. Drug Invest 1992; 4: 30-3
11. Nesto RW, White HD, Wyme J, et al. Comparison of nifedipine and isosorbide dinitrate when added to maximum propranolol therapy in stable angina pectoris. Am J Cardiol 1987; 60: 256
12. Packer M. Combined use of calcium channel blockade in angina pectoris. N Engl J Med 1989; 320: 709-17
13. Rutherford JD, Braunwald E. Chronic ischemic heart disease: management. In: Braunwald E, editor. Heart disease, a textbook of cardiovascular medicine. 4th ed. Philadelphia: Saunders, 1992: 1307
14. Vetrovec GW, Dailey S, Kay G, et al. Haemodynamic and electrophysiological effects of amlodipine, a new long-acting calcium antagonist. Postgrad Med J 1991; 67 Suppl. 5: S60-1
15. Ekelund LG, Oro L. Antianginal efficiency of nifedipine with and without a beta blocker, studied with exercise test. Clin Cardiol 1979; 2: 203-11
16. Tweddel AC, Beatti JM, Murray RG, et al. The combination of nifedipine and propranolol in the management of patients with angina pectoris. Br J Clin Pharmacol 1981; 12: 229-33
17. O'Keefe JC, Creamer JE, Banim SO. Efficacy of nisoldipine combined with beta adrenergic-blocking drugs in the treatment of chronic stable angina. Clin Cardiol 1987; 10: 345-50
18. Di Bianco R, Schoomaker FW, Singh JB, et al. Amlodipine combined with β-blockade for chronic angina: results of a multicenter, placebo-controlled, randomized, double-blind study. Clin Cardiol 1992; 15: 519-24
19. Borg G, Hassmen P, Lagerstrom M. Perceived exertion related to heart rate and blood laclate during arm and leg exercise. Eur J Appl Physiol 1987; 65: 679-83
20. Crouse LJ, Harbrecht JJ, Vaceck JL, et al. Exercise echocardiography as a screening test for coronary artery disease and correlation with coronary angiography. Am J Cardiol 1991; 67: 1213-8
21. Ryan T, Armstrong WF, O'Donell JA, et al. Risk stratification after acute myocardial infarction by means of exercise two-dimensional echocardiography. Am Heart J 1987; 114: 1305-16
22. Bolognese L, Sarasso G, Bongo AS, et al. Stress testing in the period after infarction. Circulation 1991; 83 Suppl. III: III-32-7
23. Lattanzi F, Picano E, Bolognese L, et al. Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Circulation 1991; 83: 1256-62
24. Picano E. Stress echocardiography. From pathophysiologic toy to diagnostic tool. Circulation 1992; 85: 1604-12
25. Picano E, Lattanzi F, Masini M, et al. Usefulness of the dipyridamole-exercise echocardiography test for diagnosis of coronary artery disease. Am J Cardiol 1988; 62: 67-70
26. Bairey CN, Rozanski A, Berman DS. Exercise echocardiography: ready or not? J Am Coll Cardiol 1988; 11: 1355-8
27. Gobel FL, Nordstrom LA, Nelson RR, et al. The rate pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation 1978; 57: 549-56
28. Kodama Y, Yokota M, Miyahara T, et al. Effect of antianginal agents on the relationship between rate-pressure product and myocardial oxygen uptake. Am Heart J 1993; 126: 587-93